Changes in the RAND SF-36 from baseline to 3 months: exploratory secondary analyses post intervention
| Control | Intervention | Mean difference | 95% CI | p Value | |||
| Baseline n=18 | Δ 3 months n=15 | Baseline n=16 | Δ 3 months n=15 | ||||
| ΔSF-36-physical functioning | 17.5 (0 to 38.8) | 5.0* (0 to 25.0) | 27.5 (10 to 53.8) | 20.0* (8.8 to 30.0) | 8.3 | −4.27 to 20.72 | 0.19 |
| ΔSF-36-physical role functioning | 12.5 (0 to 75.0) | 0 (0 to 50.0) | 25 (0 to 43.8) | 25.0 (−25 to 81.2) | 15.2 | −15.95 to 46.4 | 0.33 |
| ΔSF-36-emotional role functioning | 66.7 (0 to 100) | 0 (−33.3 to 0) | 33 (0 to 100) | 16.7* (0 to 100) | 27.8 | −3.1 to 58.8 | 0.08 |
| ΔSF-36-vitality | 35.0 (8.8 to 61.3) | 10 (−10.0 to 30) | 35 (17.5 to 48.8) | 17.5* (3.8 to 23.0) | 14.6 | −1.27 to 30.4 | 0.07 |
| ΔSF-36-emotional well-being | 48.0 (42.0 to 65.0) | 16.0* (8.0 to 24.0) | 56.0 (46.0 to 63.0) | 26.0* (10.0 to 38.0) | 4.6 | −10.31 to 19.6 | 0.53 |
| ΔSF-36-social role functioning | 45.0 (25.0 to 78.1) | 12.5 (0 to 47.5) | 50.0 (25.0 to 87.5) | 25.0* (9.4 to 50.0) | 15.4 | −4.01 to 34.88 | 0.12 |
| ΔSF-36-bodily pain | 45.0 (22.5 to 68.3) | 0 (−22.5 to 10.0) | 33.8 (14.3 to 52.5) | 16.3* (0 to 28.1) | 20.7† | 3.21 to 38.29 | 0.02† |
| ΔSF-36-general health | 42.5 (25.0 to 55.0) | 0 (−5.0 to 10.0) | 40 (26.3 to 53.8) | 10* (5 to 21.3) | 9.7† | 1.83 to 17.58 | 0.02† |
| ΔSF-36-MCS | 43.1 (35.0 to 48.8) | 3.8 (−2.2 to 9.6) | 40.8 (32.3 to 49.8) | 10.3 (3.8 to 19.2) | 3.0 | −7.67 to 13.66 | 0.57 |
| ΔSF-36-PCS | 27.8 (19.7 to 38.8) | −3.6 (−5.1 to 6.3) | 31.8 (19.3 to 34.8) | 3.8* (−2.3 to 13.9) | 4.6 | −2.28 to 11.55 | 0.18 |
Missing data: control n=3, intervention n=2.
*Significant intragroup difference from baseline p<0.05.
†Parameters with significant difference between groups from baseline to 3 months in p value column, p<0.05.
MCS, mental component score; PCS, physical component score; SF-36, Short-Form 36.